<bill session="112" type="h" number="1055" updated="2023-01-11T13:20:22Z">
  <state datetime="2011-03-11">REFERRED</state>
  <status>
    <introduced datetime="2011-03-11"/>
  </status>
  <introduced datetime="2011-03-11"/>
  <titles>
    <title type="display">Part D Off-Label Prescription Parity Act</title>
    <title type="official" as="introduced">To amend title XVIII of the Social Security Act to permit coverage of certain covered part D drugs for uses that are determined to be for medically accepted indications based upon clinical evidence in peer reviewed medical literature.</title>
    <title type="short" as="introduced">Part D Off-Label Prescription Parity Act</title>
  </titles>
  <sponsor bioguide_id="T000238"/>
  <cosponsors>
    <cosponsor bioguide_id="B001275" joined="2011-03-17"/>
    <cosponsor bioguide_id="B001248" joined="2011-03-11"/>
    <cosponsor bioguide_id="C001060" joined="2011-03-11"/>
    <cosponsor bioguide_id="G000544" joined="2011-03-14"/>
    <cosponsor bioguide_id="H001054" joined="2011-03-11"/>
    <cosponsor bioguide_id="J000288" joined="2011-03-29"/>
    <cosponsor bioguide_id="M001149" joined="2011-11-14"/>
  </cosponsors>
  <actions>
    <action datetime="2011-03-11">
      <text>Introduced in House</text>
    </action>
    <action datetime="2011-03-11" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2011-03-11">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2011-03-15">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2011-03-17">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2011-03-21T21:13:10Z" status="Introduced in House">Part D Off-Label Prescription Parity Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to permit a prescription drug plan (PDP) sponsor offering a PDP or a MedicareAdvantage (MA) organization offering an MA-PD plan to offer coverage of covered part D drugs for uses that are determined to be for medically accepted indications based upon: (1) guidance provided by the Secretary of Health and Human Services (HHS) for determining accepted uses of covered part D drugs; and (2) supportive clinical evidence in peer reviewed medical literature.</summary>
</bill>
